The Patent Finder

Terms ending in 2044

Pfizer Inc.

Every in-force patent on Pfizer Inc.'s record whose computed term ends in 2044, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresConfidence
US 12,758,554Stable Immediate Release Tablet and Capsule Formulations of 1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 12,281,127Pyrido[4,3-d]pyrimidine Compounds
In force
 · Medium confidence
Pfizer Inc.In forceMedium confidence
US 12,760,019Novel SIK Inhibitors
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 12,655,157SPIRO[BENZO[D]THIAZOLE-6 ,4'- Piperidine as Acc Inhibitors
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
US 12,637,461Compounds for the Activation of Ampk
In force
 · High confidence
Pfizer Inc.In forceHigh confidence
5 of 5 patents shown. Soonest term end first, then patent number.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited